MetaVia Investor Relations Material

MetaVia Inc is a U.S.-based biotechnology company focused on developing treatments for metabolic and rare genetic diseases. The company is engaged in the research and clinical development of novel therapeutics targeting underlying disease mechanisms, with a goal of addressing unmet medical needs. MetaVia utilizes proprietary technology platforms and collaborates with research institutions to advance its pipeline. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.